Burnout? What Burnout? – ASH Clinical News
Burnout? What Burnout? – Editor’s Corner, Viewpoints – ASH Clinical News
Related Articles
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment Options | JCO Precision Oncology
PURPOSEPrecision oncology connects highly complex diagnostic procedures with patient histories to identify individualized treatment options in interdisciplinary molecular tumor boards (MTBs). Detailed data on MTB-guided…
Cancer Tag Ontology
This Cancer Tag Ontology page’s aim is to develop and organize hashtags to promote better cancer care for patients, caregivers, healthcare professionals and all with…
Genomic Profiling of Small-Bowel Adenocarcinoma
This cohort study evaluates the genomic profile of patients with small-bowel adenocarcinoma compared with colorectal cancer and gastric carcinoma.
The Landscape of Circulating Tumor DNA (ctDNA) in Appendiceal Adenocarcinoma
Abstract. Purpose: Appendiceal adenocarcinoma (AA) is a rare malignancy with distinct histopathologic subtypes and a natural history with metastasis primarily limited to the peritoneum. Little…
New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer | Personalis
Results demonstrate the importance of ultra-sensitive ctDNA detection in lung cancer FREMONT, Calif. –(BUSINESS WIRE)–Jan. 13, 2025– Personalis, Inc . (Nasdaq: PSNL), in collaboration with…
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients
MicroabstractWe analyzed vaccination rates and associated outcomes of patients with multiple myelom in the INSIGHT MM study. Influenza vaccination in the prior 2 years and…
High platelet count is associated with low bone mineral density: The MrOS Sweden cohort
Osteoporosis International – In elderly ambulatory men, high platelet and high neutrophil counts are related to low bone mineral density (BMD), after adjustment for relevant…
Osteonecrosis of the Jaw in Patients Receiving Zoledronic Acid for Bone Metastases
This cohort study defines the cumulative incidence of osteonecrosis of the jaw at 3 years in patients receiving zoledronic acid for metastatic bone disease from…
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
Supportive Care in Cancer – Patients with non-Hodgkin lymphoma (NHL) have a median age of 67, with 70% surviving over 5 years. Chemotherapy for aggressive…
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial
Micro-AbstractIn patients with newly diagnosed lymphoma, low bone mineral density (BMD) is common at diagnosis and worsens with therapy. Our randomized phase III trial demonstrates…